LX1033

Lexicon Completes Phase 2 Study Of LX1033 In IBS-d
Yahoo
Tue, 12/3/13 - 09:26 am
Lexicon Pharmaceuticals
IBS-d
LX1033
US FDA grants fast track status to Lexicon's LX1033
Pharmaceutical Business Review
Mon, 12/24/12 - 10:55 am
FDA
Lexicon Pharmaceuticals
LX1033
D-IBS